Role of mucosal-protective agents, rebamipide and polaprezinc, in post-gastric endoscopic submucosal dissection ulcer healing, a randomized controlled study
Not Applicable
- Conditions
- superficial gastrointestinal neoplasms
- Registration Number
- JPRN-UMIN000006233
- Lead Sponsor
- Hiraka general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
the patients who undergo additive operation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PPI with mucosal-protective agents, at least in gastric antrum, might contribute to stabilize the efficacy of post-ESD ulcer healing.
- Secondary Outcome Measures
Name Time Method